To kick off the calendar year with a bang, OMEGA has unveiled an entirely new Speedmaster model that answers one of the range’s long-lingering question marks. For the first time ever, the new ...
Swiss luxury watchmaker OMEGA has introduced the Speedmaster Moonphase Meteorite collection to commemorate the historic 1969 Moon landing. The 43 mm timepieces, available in two stainless steel ...
An extremely mild case of that phobia, “chronochromophobia,” might be blocking your way to discover a lively world of watches that use colors to brighten things up — the multicolored Omega Speedmaster ...
Boehringer Ingelheim’s investigational schizophrenia candidate has failed to improve cognitive impairment or functioning in a trio of late-stage trials. The phase 3 program missed both primary ...
Dublin-based Platinum Travel, run by directors Austin Carroll and Ciara Foley, is destined for liquidation after it ceased trading days before Christmas. Sources say that initial calculations show ...
The researchers analysed oxygen isotopes from 14 samples from the Moon and carried out 191 measurements on minerals from Earth. Isotopes are varieties of the same element that differ only in the ...
Boehringer Ingelheim today announced top-line results from the Phase III CONNEX clinical program in cognitive impairment in adults with schizophrenia, showing primary and key secondary endpoints ...
Two lunar landers built by private companies in the US and Japan have left Earth aboard a SpaceX rocket as part of a rideshare to the Moon. The Falcon 9 took off from the Kennedy Space Center in ...
100 years after the first moon phase watch from Patek Philippe, Omega has announced a new pair, the Speedmaster Moonphase Meteorite collection. Unlike most moon phase watches, this pair represents the ...
Omega has expanded its Speedmaster lineup with a captivating new addition: the Speedmaster Moonphase Meteorite. Featuring a dial made from a slice of genuine meteorite, this timepiece adds an ...
Get Instant Summarized Text (Gist) Trastuzumab emtansine (T-DM1) significantly improves long-term survival in high-risk HER2-positive breast cancer patients post-surgery, reducing the risk of ...